• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    Synageva BioPharma Corp. (GEVA)

    -NasdaqGS
    238.60 0.00(0.00%) Jun 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:238.60
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:185.00
    Beta:-0.05
    Earnings Date:Jul 28 - Aug 3 (Est.)
    Day's Range:N/A - N/A
    52wk Range:60.19 - 239.20
    Volume:0
    Avg Vol (3m):895,402
    Market Cap:8.87B
    P/E (ttm):N/A
    EPS (ttm):-6.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GEVA

    Comparison

    Symbol% ChgMkt Cap
    GEVA 0.00%8.87B
    GILDUp 0.54%169.98B
    MRKDown 0.21%162.59B
    PFEDown 0.36%204.74B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,519.75
    Ex-Dividend Date:30-Dec-08

    Analysts

    Annual EPS Est (Dec-15) :-7.33
    Quarterly EPS Est (Jun-15) :-1.76
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synageva BioPharma Corp. operates as a biopharmaceutical company in the United States. It focuses on the discovery, development, and commercialization of therapeutic products for patients with rare diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback